OSE Immunotherapeutics Will Participate in HealthTech Investor Days (HTID)
NANTES, France, June 24, 2019 (GLOBE NEWSWIRE) -- OSE Immunotherapeutics (ISIN: FR0012127173; Mnémo: OSE) will participate in the first HealthTech Investor Days business event, hosted by France Biotech on June 24th & 25th in Paris. This first ever …